Healthcare
Live Price
Offline$0.1994
+0.00% today
1Y Change
-68.35%
Window
Jun 23, 2025 → Jun 11, 2026
Coverage: 244 bars · Jun 23, 2025 → Jun 11, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Quantum-Si incorporated (QSIAW) is a Healthcare stock with a market cap of $190.00M and listed on NASDAQ. The stock last traded around $0.20 and down 68.3% across the available one-year price window (Jun 23, 2025 → Jun 11, 2026). Baseline metrics include revenue growth of -20.3%, EPS growth of +28.2%, a dividend yield of 0.0%. What stands out right now is revenue -20.3%, EPS +28.2%, free cash flow -5.3% with operating margin -4766.0% and ROIC -51.7%. Valuation already assumes a fairly strong business story at price/sales 77.3. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines QSIAW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
QSIAW
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
QSIAW Max Drawdown
-87.35%
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for QSIAW and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$0.0
FY Net Income
-$95.0M
+28.3% YoY
Free Cash Flow
-$72.6M
+28.4% YoY
Revenue Growth
-20.3%
EPS Growth
+28.2%
Gross Margin
-135.5%
Net Margin
-4160.1%
Income statement
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | 2M | 3M | 1M | 0 | 0 |
| Gross Profit | -3M | 2M | 488K | 0 | 0 |
| Operating Income | -97M | -109M | -111M | -124M | -97M |
| EBITDA | -93M | -104M | -92M | -112M | -94M |
| Net Income | -101M | -101M | -96M | -132M | -95M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
USD
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Cash & Equivalents | 22M | 49M | 134M | 84M | 36M |
| Total Assets | 246M | 248M | 298M | 391M | 503M |
| Total Liabilities | 25M | 32M | 27M | 33M | 26M |
| Shareholder Equity | 220M | 215M | 272M | 359M | 477M |
| Total Debt | 4M | 13M | 15M | 17M | 8M |
| Net Debt | -17M | -36M | -119M | -67M | -28M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
67M
+26.2% YoY
Capital Expenditures
6M
+46.3% YoY
Free Cash Flow
73M
+28.4% YoY
Key ratios
Gross Margin
-135.5%
Operating Margin
-4766.0%
Net Margin
-4160.1%
ROE
-43.9%
Debt / Equity
0.02x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.